These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15484369)

  • 1. RTV patent under fire.
    Roehr B
    IAPAC Mon; 2004 Jun; 10(6):189-90. PubMed ID: 15484369
    [No Abstract]   [Full Text] [Related]  

  • 2. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents.
    Malakoff D
    Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775
    [No Abstract]   [Full Text] [Related]  

  • 3. Abbott announces RTV price concessions.
    Alcorn K
    IAPAC Mon; 2004 Mar; 10(3):77. PubMed ID: 15108678
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug pricing. AHF sues Abbott over drug price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981
    [No Abstract]   [Full Text] [Related]  

  • 5. Pricing. Pharmacies file Norvir suits against Abbott.
    AIDS Policy Law; 2007 Nov; 22(21):9. PubMed ID: 18225373
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug pricing. Dismissal is denied in Norvir price-boosting suit.
    AIDS Policy Law; 2005 Nov; 20(21):6. PubMed ID: 16333878
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA issues warning letter to Abbott over Norvir pricing spin.
    GMHC Treat Issues; 2004; 18(5-6):11. PubMed ID: 15359439
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug pricing. HIV/AIDS patients file federal antitrust suit against Abbott.
    AIDS Policy Law; 2004 May; 19(9):9. PubMed ID: 15202406
    [No Abstract]   [Full Text] [Related]  

  • 9. Five years later: re-examining the financial burden of boosting with Norvir.
    Marquez C; Guglielmo BJ; Klausner JD
    AIDS; 2008 Nov; 22(17):2402-4. PubMed ID: 18981784
    [No Abstract]   [Full Text] [Related]  

  • 10. Advertisements. FDA orders Abbott to change misleading ads for Norvir.
    AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversy over ritonavir price increase.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032179
    [No Abstract]   [Full Text] [Related]  

  • 12. Access to drugs: the case of Abbott in Thailand.
    Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S
    Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589
    [No Abstract]   [Full Text] [Related]  

  • 13. Norvir hangover.
    Clifton CE
    Posit Aware; 2004; 15(2):7-9. PubMed ID: 15106524
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy. Direct purchasers may proceed with claims against Abbott.
    AIDS Policy Law; 2011 Mar; 26(4):5. PubMed ID: 21539034
    [No Abstract]   [Full Text] [Related]  

  • 15. Abbott Laboratories' pricing malfunction.
    Salyer D
    Surviv News (Atlanta Ga); 2004; 15(3):18-9. PubMed ID: 15218860
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug pricing. AHF presses for indemnification over Norvir price increase.
    AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045980
    [No Abstract]   [Full Text] [Related]  

  • 17. Open letter from ATAC to Abbott's CEO, Miles White.
    Dee L; Sharp M
    GMHC Treat Issues; 2003 Dec; 17(12):5. PubMed ID: 15011642
    [No Abstract]   [Full Text] [Related]  

  • 18. Abbott expands low cost Kaletra.
    AIDS Patient Care STDS; 2006 Oct; 20(10):731-2. PubMed ID: 17083155
    [No Abstract]   [Full Text] [Related]  

  • 19. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir.
    Huff B
    GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438
    [No Abstract]   [Full Text] [Related]  

  • 20. Abbott Laboratories increases Norvir price fivefold.
    James JS
    AIDS Treat News; 2003 Dec; (397):3-5. PubMed ID: 14989182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.